Earnings Feed
Start Free
Viridian Therapeutics, Inc.\DE·4

Feb 3, 6:13 PM ET

Katz Barrett 4

4 · Viridian Therapeutics, Inc.\DE · Filed Feb 3, 2022

Insider Transaction Report

Form 4
Period: 2022-02-02
Viridian Therapeutics, Inc.\DEVRDN
Katz Barrett
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-02-02+110,000→ 110,000 total
    Exercise: $18.51Exp: 2032-02-02→ Common Stock (110,000 underlying)
Footnotes (1)
  • [F1]The option vests in equal monthly installments through February 2, 2026, subject to the Reporting Person's continued service to Issuer through each vesting date.

Documents

2 files